ELECTROVE Trademark

Trademark Overview

On Tuesday, June 17, 2014, a trademark application was filed for ELECTROVE with the United States Patent and Trademark Office. The USPTO has given the ELECTROVE trademark a serial number of 86312101. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 5, 2024. This trademark is owned by Glaxo Group Limited. The ELECTROVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
electrove

General Information

Serial Number86312101
Word MarkELECTROVE
Filing DateTuesday, June 17, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 5, 2024
Registration Number5357407
Registration DateTuesday, December 19, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 30, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, June 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 20, 2014NEW APPLICATION ENTERED
Thursday, April 30, 2015SOU EXTENSION 1 GRANTED
Thursday, August 21, 2014ASSIGNED TO EXAMINER
Friday, August 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 20, 2015ASSIGNED TO EXAMINER
Thursday, April 30, 2015SOU TEAS EXTENSION RECEIVED
Thursday, April 30, 2015SOU EXTENSION 1 FILED
Thursday, May 12, 2016SOU EXTENSION 3 GRANTED
Saturday, May 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 19, 2015SOU TEAS EXTENSION RECEIVED
Monday, October 19, 2015SOU EXTENSION 2 FILED
Thursday, October 29, 2015SOU EXTENSION 2 GRANTED
Thursday, October 29, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 18, 2016SOU TEAS EXTENSION RECEIVED
Monday, April 18, 2016SOU EXTENSION 3 FILED
Thursday, October 13, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, May 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2016SOU EXTENSION 4 FILED
Saturday, October 15, 2016SOU EXTENSION 4 GRANTED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 24, 2017TEAS DELETE 1(B) BASIS RECEIVED
Friday, June 9, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, June 16, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 19, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 18, 2017ASSIGNED TO PETITION STAFF
Friday, October 20, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, November 14, 2017ELECTRONIC RECORD REVIEW COMPLETE
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 5, 2024CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

electrove pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological